How long is the usual course of treatment with upadatinib?

Upadacitinib is an oral, selective JAK1 inhibitor, mainly used to treat a variety of chronic inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, etc. Since these diseases themselves are long-term, chronic and prone to relapse, the treatment goals are usually to control symptoms, delay the progression of the disease, and improve the quality of life. Therefore, in most cases, upadatinib needs to be taken long-term to maintain the stability of the disease.

Whether long-term use of upadatinib is needed depends on the specific type of disease and the development of the individual's disease. For example, for patients with moderate to severe rheumatoid arthritis, if their symptoms are significantly improved and inflammation indicators decrease after using upadatinib, doctors will generally recommend continuing to take the medication to prevent the disease from recurring. If the patient's condition continues to be relieved, the doctor may also try to reduce the dose after a certain period of time, but this usually requires strict monitoring and gradual progress, and the drug cannot be stopped or the dose changed at will.

Upadatinib is not a short-term "cure" drug, but a "control" treatment with the goal of long-term stabilization of the disease. If there is no other alternative treatment after stopping the drug, the condition may rebound within a short period of time and may even be worse than before taking the drug. In addition, long-term use of upadatinib also requires regular blood tests and liver and kidney function assessments to monitor potential side effects and adverse reactions to ensure drug safety.
In short, the treatment course of upadatinib is usually longer and may even require many years or even lifelong use. During use, patients should strictly follow the doctor's instructions to take the medicine, review it regularly, and should not stop taking the medicine or reduce the dosage on their own. If adverse reactions or poor effects occur during medication, you should communicate with your doctor promptly to evaluate whether the treatment plan needs to be adjusted. Under scientific and standardized management, upadatinib can help patients control their condition and improve their quality of life in the long term.
Reference: https://www.rinvoq.com/